See more : Hangzhou Juheshun New Material Co., Ltd. (605166.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Glass House Brands Inc. (GLASF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Glass House Brands Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Bufab AB (publ) (BUFAB.ST) Income Statement Analysis – Financial Results
- Paref SA (PAR.PA) Income Statement Analysis – Financial Results
- Artemis Medicare Services Limited (ARTEMISMED.NS) Income Statement Analysis – Financial Results
- Vinda International Holdings Limited (VDAHY) Income Statement Analysis – Financial Results
- Sanei Architecture Planning Co.,Ltd. (3228.T) Income Statement Analysis – Financial Results
Glass House Brands Inc. (GLASF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.glasshousebrands.com
About Glass House Brands Inc.
Glass House Brands Inc. cultivates, manufactures, retails, and distributes raw cannabis, cannabis oil, and cannabis consumer goods to wholesalers and consumer packaged goods retail stores. It offers cannabis products under the Glass House Farms, Forbidden Flowers, and Mama Sue brands. Glass House Brands Inc. was founded in 2015 and is headquartered in Long Beach, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 160.84M | 90.89M | 69.45M | 48.26M | 16.94M | 8.97M |
Cost of Revenue | 79.87M | 69.35M | 53.43M | 29.52M | 8.46M | 3.75M |
Gross Profit | 80.97M | 21.54M | 16.02M | 18.74M | 8.48M | 5.22M |
Gross Profit Ratio | 50.34% | 23.70% | 23.07% | 38.83% | 50.05% | 58.19% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 60.22M | 55.71M | 42.86M | 20.68M | 14.55M | 5.01M |
Selling & Marketing | 2.84M | 3.43M | 3.53M | 1.49M | 912.84K | 143.22K |
SG&A | 63.06M | 59.14M | 46.39M | 22.17M | 266.74K | 5.15M |
Other Expenses | 67.44M | 12.30M | 4.77M | 2.58M | 0.00 | 0.00 |
Operating Expenses | 130.50M | 71.44M | 51.16M | 24.74M | 266.74K | 5.88M |
Cost & Expenses | 210.36M | 140.79M | 104.58M | 54.26M | 266.74K | 9.63M |
Interest Income | 9.77M | 56.47K | 64.84K | 115.57K | 3.37M | 288.84K |
Interest Expense | 0.00 | 7.61M | 2.74M | 2.18M | 193.24K | 0.00 |
Depreciation & Amortization | 14.63M | 11.81M | 4.73M | 2.71M | 1.46M | 767.57K |
EBITDA | -64.84M | -16.75M | -33.27M | -5.78M | -6.98M | 65.98K |
EBITDA Ratio | -40.31% | -9.26% | -38.00% | -6.44% | -1.57% | 0.74% |
Operating Income | -49.53M | -49.90M | -35.14M | -6.00M | -266.74K | -701.59K |
Operating Income Ratio | -30.79% | -54.90% | -50.60% | -12.44% | -1.57% | -7.82% |
Total Other Income/Expenses | -38.59M | 19.04M | -5.57M | -4.24M | -9.50M | -252.50K |
Income Before Tax | -88.12M | -30.85M | -41.07M | -10.24M | 2.90M | -954.09K |
Income Before Tax Ratio | -54.79% | -33.95% | -59.14% | -21.22% | 17.10% | -10.64% |
Income Tax Expense | 9.94M | 4.74M | 3.30M | 6.42M | 972.52K | 357.35K |
Net Income | -98.27M | -35.60M | -44.37M | -16.66M | 2.90M | -1.52M |
Net Income Ratio | -61.10% | -39.16% | -63.88% | -34.52% | 17.10% | -16.98% |
EPS | -1.65 | -0.55 | -1.13 | -0.78 | 0.00 | -0.07 |
EPS Diluted | -1.39 | -0.55 | -1.10 | -0.78 | 0.00 | -0.06 |
Weighted Avg Shares Out | 60.65M | 64.18M | 39.24M | 21.27M | 0.00 | 23.19M |
Weighted Avg Shares Out (Dil) | 72.03M | 64.18M | 40.28M | 21.27M | 0.00 | 24.26M |
Top Marijuana Stocks to Watch This Week in June: High-Growth Picks
Here Are 3 Marijuana Stocks For You Today
Here Are 3 Top Marijuana Stock For Your Portfolio
June 2024 Watchlist: Leading US Cannabis Stocks
Top Marijuana Stocks to Watch Next Week: Your Guide to Potential High-Growth Investments
Glass House Withdraws Defamation Suit, Citing Catalyst Financial Viability Concerns and Harassment Threats to Customers
Glass House Withdraws Defamation Suit, Citing Catalyst Financial Viability Concerns and Harassment Threats to Customers
Glass House Brands Inc. (GLASF) Q1 2024 Earnings Call Transcript
High Potential: Top U.S. Cannabis Stocks Poised for Growth
Top U.S. Cannabis Stocks Flourishing in the Last Six Months
Source: https://incomestatements.info
Category: Stock Reports